Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 17Recruiting 9Active not recruiting 9Unknown 8Terminated 4Withdrawn 3Not yet recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Uterine Cervical Neoplasms 2Vaginal Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Lung Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Adenocarcinoma 1

Interventions

Docetaxel 11Prednisone 10Leuprolide 10Magnetic Resonance Spectroscopy 9bicalutamide 8Radiotherapy 7Abiraterone Acetate 7Biopsy 6gallium 68 PSMA-11 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Surveys and Questionnaires 5Metformin 5Goserelin 5radium Ra 223 dichloride 4enzalutamide 4apalutamide 4Specimen Handling 4Injections 4Androgen Antagonists 4pembrolizumab 3orteronel 3cabazitaxel 3abiraterone 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pioglitazone 3Paclitaxel 3Exercise 3Brachytherapy 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × Brachytherapy × Clear all
NCT01802307 2021-05-11

Focal Therapy for Prostate Cancer

University of Maryland, Baltimore

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT04399824 2020-11-06

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Jonsson Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT01859689 2020-07-27

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡